Eligo Bioscience is an innovation-driven biotechnology company, spun out of MIT and Rockefeller University, and based in Paris, France.
Eligo Bioscience has raised more than 20 million euros from leading investors in Silicon Valley and in France to develop next-generation drugs that are based on the genetic engineering of bacteria and their viruses and aim to address unmet medical need in microbiome-associated diseases.
The Company has been elected as one of the 30 Most Innovative Companies by the World Economic Forum in 2017, has received multiple international awards for pioneering work in the field of synthetic biology, and has been featured in international media and scientific journals such as Nature Biotechnology, Science, The Economist, The BBC and The New York Times.
Eligo Bioscience has attracted highly diverse top talent from all over the world, currently numbering over 40 Eligonauts from more than 10 countries, who are driven, passionate, and motivated to impact the lives of patients by applying cutting-edge science to save lives and treat chronic diseases.
We believe that by enabling targeted in-situ gene editing of the microbiome, our therapeutics will have the potential to drastically change the disease course in patients with autoimmune diseases, inflammatory diseases and cancer. Our proprietary platforms enable removing, editing, or adding functionality to the microbiome with unprecedented precision, allowing us to influence the host response in a radically new way.
At Eligo, we furthermore benefit from ongoing collaborations with key opinion leaders in specific therapeutic areas, greatly speeding up our research and development efforts.
Eligo embraces diversity, equal opportunity and inclusion and is committed to building diverse teams. We strive to create an inclusive workplace that cultivates innovation through collaboration and empowers people to unleash their full potential. We care for one another, communicate and listen, jump in to help where needed, show flexibility, laugh a lot, and have fun together in the process of creating.
Our growing pipeline is rapidly progressing and we are looking for a highly motivated and creative Senior Immunologist to drive the immunological understanding for one of our Lead programs.
For each program, we start our thinking in the patient and consider which problems their disease requires solving. Your leadership in immunology will be vital to ask the right immunological questions and lead the science that delivers the answers.
You will have the opportunity to progress and develop research into the immunological pathways underpinning our mechanism of action and improve the therapeutic approach for one of our Lead programs.
Your role would include working in partnership with a dynamic cross-functional project team that combines microbiology, synthetic biology, immunology, bioinformatics and automation.
Join us as we build the future of precision microbiome medicines!